Ratios Reveal: Breaking Down Mind Medicine Inc (MNMD)’s Financial Health

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

Mind Medicine Inc (NASDAQ: MNMD) closed the day trading at $5.85 down -5.49% from the previous closing price of $6.19. In other words, the price has decreased by -$5.49 from its previous closing price. On the day, 1.54 million shares were traded. MNMD stock price reached its highest trading level at $6.065 during the session, while it also had its lowest trading level at $5.66.

Ratios:

For a better understanding of MNMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.00 and its Current Ratio is at 7.20. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.

On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’25 when Barrow Robert sold 21,208 shares for $6.74 per share. The transaction valued at 142,942 led to the insider holds 856,556 shares of the business.

Karlin Daniel sold 6,836 shares of MNMD for $46,075 on Mar 25 ’25. The Chief Medical Officer now owns 446,177 shares after completing the transaction at $6.74 per share. On Mar 25 ’25, another insider, Sullivan Mark, who serves as the Chief Legal Officer of the company, sold 6,576 shares for $6.74 each. As a result, the insider received 44,322 and left with 316,621 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 466529920 and an Enterprise Value of 189017904.

Stock Price History:

The Beta on a monthly basis for MNMD is 2.36, which has changed by -0.4060914 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is -18.53%, while the 200-Day Moving Average is calculated to be -16.68%.

Shares Statistics:

Over the past 3-months, MNMD traded about 1.98M shares per day on average, while over the past 10 days, MNMD traded about 1175030 shares per day. A total of 75.37M shares are outstanding, with a floating share count of 74.09M. Insiders hold about 1.20% of the company’s shares, while institutions hold 49.60% stake in the company. Shares short for MNMD as of 1741910400 were 11372547 with a Short Ratio of 5.75, compared to 1739491200 on 10885373. Therefore, it implies a Short% of Shares Outstanding of 11372547 and a Short% of Float of 15.100000999999999.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular